Isoforms of autophagy-related proteins: role in glioma progression and therapy resistance

Elizaveta Belyaeva1, Rajesh Kumar Kharwar2, Ilya V Ulasov3

  • 1Group of Experimental Biotherapy and Diagnostics, Institute for Regenerative Medicine, World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow, Russia, 119991.

Insights

Autophagy, a cellular recycling process, helps cells adapt to stress and is explored for anticancer therapy in malignant glioma. Its molecular mechanisms, especially involving autophagy-related proteins, are key to understanding glioma progression and treatment.

Area of Science:

  • Cellular Biology
  • Molecular Oncology

Background:

  • Autophagy is a cellular process for recycling degraded components.
  • It aids cell adaptation to stress and nutrient deprivation, maintaining homeostasis.
  • Autophagy is increasingly recognized as a form of programmed cell death.

Purpose of the Study:

  • To review the current understanding of autophagy mechanisms.
  • To explore the role of autophagy-related proteins in glioma.
  • To discuss autophagy's potential in malignant glioma treatment.

Main Methods:

  • Literature review of autophagy mechanisms.
  • Analysis of molecular pathways involved in autophagy.
  • Examination of recent studies on autophagy-related proteins in glioma.

Main Results:

  • Autophagy is crucial for cell survival under stress.
  • Autophagy-related proteins are implicated in glioma progression.
  • The precise molecular mechanisms of autophagosome formation require further investigation.

Conclusions:

  • Autophagy plays a dual role in cancer, potentially promoting or inhibiting tumor growth.
  • Autophagy-related proteins and their isoforms are critical targets for glioma therapy.
  • Further research into autophagy's molecular intricacies is essential for developing effective anticancer strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.8K